β Scribed by Kossovsky, Nir ;Brandegee, Bear
No coin nor oath required. For personal study only.
Although reducing risks for medical devices is an element of product liability risk management, reducing risks for medical device manufacturers is the ultimate objective. With so much riding on the product development pipeline, what can manufacturers do to ensure a successful launch and healthy return on their investment? We argue in this editorial that the operating environment for the medical device industry is so dynamic that compliance is not enough. Instead, we suggest that risk abatement must become a part of a medical device manufacturer's operating strategy. We outline a robust risk abatement strategy involving corporate cultural changes, scenario modeling tools, and implementation systems.
π SIMILAR VOLUMES
## Abstract Information plays a critical role in business today. Only companies that can increase business value using information will survive, says the author. But corporations must do more than fix the way they create information value. They need a brand new model that combines both IT and busin
An emerging technology subtype that has been adopted by formulators to address low-solubility issues is the supersaturating drug delivery system; this system is based on the "spring" and "parachute" design elements, which have been applied to lipid-based formulations, S(M)EDDS, solid dispersions, na